A-SPINE Asia Co., Ltd. (TPEX:6758)
30.10
+0.15 (0.50%)
Nov 20, 2026, 1:27 PM CST
A-SPINE Asia Market Cap
A-SPINE Asia has a market cap or net worth of 405.48 million as of November 20, 2026. It is the 39,827th most valuable company in the world and the 2,288th biggest in Taiwan. Its market cap has decreased by 21.20% in one year.
Market Cap
405.48M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#2,288 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since January 2, 2020, A-SPINE Asia's market cap has decreased from 1.20B to 405.48M, a decrease of -66.18%. That is a compound annual growth rate of -14.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 402.78M | -24.30% |
| Dec 31, 2025 | 532.11M | -1.00% |
| Dec 30, 2024 | 537.49M | 2.57% |
| Dec 29, 2023 | 524.02M | 2.37% |
| Dec 30, 2022 | 511.90M | -19.23% |
| Dec 10, 2021 | 633.81M | -18.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rossmax International | 820.03M |
| Radiant Innovation | 745.23M |
| AmCad BioMed | 699.83M |
| Carilex Medical | 651.76M |
| Cowealth Medical Holding | 635.72M |
| Diamond Biotechnology | 613.44M |
| PlexBio | 518.25M |
| DuoGenic StemCells corporation | 409.41M |